ClinicalTrials.gov
public full text
Public Domain
Global Study of Del-desiran for the Treatment of DM1
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Macrolides: a potential treatment for myotonic dystrophy type 1#483927
- Investigating the potential role of CDK13 in the transcription and stability of mutant DMPK mRNA in myotonic dystrophy type 1#990179
- Investigating the use of oligonucleotides for the treatment of muscular dystrophy#1148728
- Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1#849703
- Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial#812142
Record · ID 1140934
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive